Learning Under Treatment-Induced Label Indeterminacy with Expert Annotations of Counterfactual Outcomes: A Case Study in Neurological Prognostication
Clinical prediction models often assume outcomes are cleanly observable, but treatment decisions can render outcomes permanently unobservable for some patients The authors propose a framework that splits evaluation between "certain cases" (observed outcomes) and "uncertain cases" (counterfactual outcomes estimated by expert annotations) A novel prediction model was developed that combines labels from both case types with a tunable tradeoff mechanism Models with similar AUROC on certain cases can
Analysis
TL;DR
- Clinical prediction models often assume outcomes are cleanly observable, but treatment decisions can render outcomes permanently unobservable for some patients
- The authors propose a framework that splits evaluation between "certain cases" (observed outcomes) and "uncertain cases" (counterfactual outcomes estimated by expert annotations)
- A novel prediction model was developed that combines labels from both case types with a tunable tradeoff mechanism
- Models with similar AUROC on certain cases can differ substantially in Brier score and probability estimates for uncertain cases
- Improving alignment with uncertain-case labels generally degrades accuracy on certain cases, revealing a tradeoff that standard evaluation metrics conceal
Why It Matters
This work addresses a critical gap in clinical AI where treatment decisions create missing-not-at-random label problems, affecting model development in healthcare settings where prognostic support is most needed. For AI practitioners building models in domains with intervention-induced label gaps, this framework provides a principled approach to evaluation and training that goes beyond standard metrics.
Technical Details
- Dataset: Post-cardiac-arrest neurological prognostication cohort of 2,497 patients, with 1,429 patients (57%) having indeterminate outcomes due to treatment decisions
- Expert annotations: Independent clinical experts provided counterfactual outcome guesses for uncertain cases, creating a hybrid label space combining observed and estimated targets
- Evaluation framework: Explicitly separates model assessment into certain-case and uncertain-case streams, acknowledging that uniform evaluation is infeasible due to differing label availability
- Model architecture: A neural prediction model incorporating both certain and uncertain case labels with a configurable tradeoff parameter, evaluated against tabular baselines
- Key finding: Models with comparable certain-case AUROC showed substantial divergence in Brier scores and uncertain-case probability estimates, with optimization toward uncertain cases degrading certain-case performance
Industry Insight
- Healthcare AI developers should adopt split-evaluation frameworks when dealing with treatment-induced label gaps rather than relying solely on standard metrics computed on observed outcomes
- The observed tradeoff between certain and uncertain case performance suggests that model robustness in clinical settings requires explicit consideration of counterfactual alignment, not just historical accuracy
- Expert-annotated counterfactual labels represent a viable but imperfect signal that should be incorporated into model development pipelines for high-stakes clinical prediction tasks
Disclaimer: The above content is generated by AI and is for reference only.